Prognostic significance of total lesion glycolysis in patients with advanced non-small cell lung cancer receiving chemotherapy-Reference-Cited by-同舟云学术

Prognostic significance of total lesion glycolysis in patients with advanced non-small cell lung cancer receiving chemotherapy

Published:2012-12 Issue:12 Volume:81 Page:4179-4184
ISSN:0720-048X
Container-title:European Journal of Radiology
language:en
Short-container-title:European Journal of Radiology

Author:

Zaizen Yoshiaki,Azuma Koichi,Kurata Seiji,Sadashima Eiji,Hattori Satoshi,Sasada Tetsuro,Imamura Yohei,Kaida Hayato,Kawahara Akihiko,Kinoshita Takashi,Ishibashi Masatoshi,Hoshino Tomoaki

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference21 articles.

1. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;New England Journal of Medicine,2002

2. Preoperative staging of non-small-cell lung cancer with positron-emission tomography;Pieterman;New England Journal of Medicine,2000

3. Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review;Vansteenkiste;Lancet Oncology,2004

4. Prognosis and reevaluation of lung cancer by positron emission tomography imaging;Easmus;Proceedings of the American Thoracic Society,2009

5. Positron emission tomography in non-small-cell cancer: prediction of response to chemotherapy by quantitative assessment of glucose use;Weber;Journal of Clinical Oncology,2003

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bronchogenic carcinoma: the added value of FDG PET/CT advanced volumetric and metabolic parameters in initial evaluation and their impact on prognosis and clinical outcome;Egyptian Journal of Radiology and Nuclear Medicine;2024-02-19

2. FDG-PET metrics in advanced non-small cell lung cancer (NSCLC): a review and meta-analysis;Clinical and Translational Imaging;2023-02-09

3. Necrosis onstaging 18F FDG PET/CT is associated with worse progression-free survival in patients with stage IIIB non-small cell lung cancer;Journal of Cancer Research and Therapeutics;2022

4. The ratio between the whole-body and primary tumor burden, measured on 18F-FDG PET/CT studies, as a prognostic indicator in advanced non-small cell lung cancer;Radiologia Brasileira;2021-10

5. Therapeutic potential of AMPK signaling targeting in lung cancer: Advances, challenges and future prospects;Life Sciences;2021-08